5 High Growth UK Stocks to Buy
Adaptimmune Therapeutics plc (NASDAQ:ADAP) is a biotechnology firm that develops tumor and cancer treatments. Some cancers that the firm is taking aim at include those of the lungs, head, and neck.
Akanda Corp. (AKAN)
Market is closed
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.40 | 29,036 | $40,650.40 | 15,684 | 2026-01-15 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.29 | 7,868 | $10,149.72 | 7,816 | 2026-01-16 | Filing |
News See All
Hedge Fund Resource Center Billionaire Hedge Funds
